Literature DB >> 18673203

Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Abba J Kastin1, Weihong Pan.   

Abstract

The two main ways for peptides in the peripheral body to enter the brain are by either saturable transport or passive diffusion across the blood-brain barrier (BBB). Saturable transport systems have the advantage of being responsive to physiological and pathological stimuli. Since saturable systems can regulate peptide entry into the brain, they have the potential to play controlling roles in feeding behavior. For therapeutic applications, however, saturable systems have the disadvantage of functioning as a threshold to limit access of large amounts of peptides into the brain. This pharmacological problem presumably would not be encountered for peptides crossing the BBB by passive diffusion, a process dependent on physicochemical properties. Thus, the gatekeeper function of the BBB can be expanded to a primary governing role, especially for entry of ingestive peptides subject to their respective saturable transport systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673203      PMCID: PMC2750905          DOI: 10.2174/138161208784705423

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  64 in total

1.  Regional differences in peptide degradation by rat cerebral microvessels: a potential novel regulatory mechanism for communication between blood and brain.

Authors:  A J Kastin; K Hahn; J E Zadina
Journal:  Life Sci       Date:  2001-08-03       Impact factor: 5.037

2.  In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier.

Authors:  G A Maresh; L M Maness; J E Zadina; A J Kastin
Journal:  Life Sci       Date:  2001-05-25       Impact factor: 5.037

3.  Interactions of IGF-1 with the blood-brain barrier in vivo and in situ.

Authors:  W Pan; A J Kastin
Journal:  Neuroendocrinology       Date:  2000-09       Impact factor: 4.914

4.  Modulation of feeding-related peptide/protein signals by the blood-brain barrier.

Authors:  Weihong Pan; Victoria Akerstrom; Jian Zhang; Vojislav Pejovic; Abba J Kastin
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

5.  Activation of urocortin transport into brain by leptin.

Authors:  A J Kastin; V Akerstrom; W Pan
Journal:  Peptides       Date:  2000-12       Impact factor: 3.750

6.  Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system.

Authors:  W Pan; A J Kastin
Journal:  Life Sci       Date:  2001-05-04       Impact factor: 5.037

7.  Chronic loss of ovarian function decreases transport of leptin into mouse brain.

Authors:  A J Kastin; V Akerstrom; L M Maness
Journal:  Neurosci Lett       Date:  2001-09-07       Impact factor: 3.046

8.  Pretreatment with glucose increases entry of urocortin into mouse brain.

Authors:  A J Kastin; V Akerstrom
Journal:  Peptides       Date:  2001-05       Impact factor: 3.750

9.  Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice.

Authors:  A J Kastin; V Akerstrom
Journal:  Neuroendocrinology       Date:  2001-04       Impact factor: 4.914

10.  Adrenomedullin and the blood-brain barrier.

Authors:  A J Kastin; V Akerstrom; L Hackler; W Pan
Journal:  Horm Metab Res       Date:  2001-01       Impact factor: 2.936

View more
  10 in total

Review 1.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

Review 2.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

3.  Insulin transport across the blood-brain barrier can occur independently of the insulin receptor.

Authors:  Elizabeth M Rhea; Christian Rask-Madsen; William A Banks
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

Review 4.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

5.  Effects of cell-type specific leptin receptor mutation on leptin transport across the BBB.

Authors:  Hung Hsuchou; Abba J Kastin; Hong Tu; Emily N Markadakis; Kirsten P Stone; Yuping Wang; Steven B Heymsfield; Streamson S Chua; Silvana Obici; I Jack Magrisso; Weihong Pan
Journal:  Peptides       Date:  2011-05-17       Impact factor: 3.750

6.  Blood-borne metabolic factors in obesity exacerbate injury-induced gliosis.

Authors:  Hung Hsuchou; Abba J Kastin; Weihong Pan
Journal:  J Mol Neurosci       Date:  2012-03-04       Impact factor: 3.444

Review 7.  Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin.

Authors:  W A Banks; A Gertler; G Solomon; L Niv-Spector; M Shpilman; X Yi; E Batrakova; S Vinogradov; A V Kabanov
Journal:  Physiol Behav       Date:  2011-06-06

Review 8.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

Review 9.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

10.  Fibroblast growth factor 19 entry into brain.

Authors:  Hung Hsuchou; Weihong Pan; Abba J Kastin
Journal:  Fluids Barriers CNS       Date:  2013-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.